OLGA TCHIKINDAS: Open Payments
NPI 1508997552 · HAMILTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 79 payments from 11 companies in 2025. Trend: 2023 $486 · 2024 $623 · 2025 $1,391
Food & beverage: $1,304Education: $87
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 16 | $282 |
| Teva Pharmaceuticals USA, Inc. | 17 | $278 |
| E.R. Squibb & Sons, L.L.C. | 16 | $277 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $172 |
| Alkermes, Inc. | 7 | $123 |
| Neurocrine BioSciences, Inc. | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $28 |
| Lundbeck LLC | 1 | $18 |
Products named: COBENFY, INVEGA SUSTENNA, CAPLYTA, UZEDY, ARISTADA, INGREZZA, REXULTI, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
